Session Tracks

This track focuses on the latest advancements in cancer treatment modalities, including targeted therapies and immunotherapies. Researchers will present novel approaches that enhance therapeutic efficacy and minimize side effects.

This session will explore the intricate biology of cancer cells and their interactions with the tumor microenvironment. Discussions will include cellular signaling pathways, immune evasion, and the role of the stroma in tumor progression.

This track highlights the discovery and validation of biomarkers that aid in cancer diagnosis and prognosis. Presentations will cover recent findings in liquid biopsies, imaging techniques, and molecular profiling.

This session will delve into cutting-edge imaging technologies that enhance cancer detection and monitoring. Topics will include novel imaging agents, machine learning applications, and the integration of imaging with therapeutic strategies.

This track will examine the role of robotic-assisted surgical techniques in cancer treatment. Experts will discuss the benefits, challenges, and outcomes associated with robotic interventions in various cancer types.

This session will investigate the relationship between viral infections and cancer development. Researchers will present findings on tumor-associated viruses and their mechanisms of oncogenesis.

This track focuses on the application of metabolomics in understanding cancer biology and treatment responses. Presentations will highlight how metabolic profiling can inform therapeutic strategies and patient management.

This session will explore the fundamental mechanisms underlying carcinogenesis and mutagenesis. Discussions will include genetic and epigenetic factors that contribute to cancer initiation and progression.

This track will cover innovative methodologies in clinical trial design and execution for cancer therapies. Researchers will share insights on adaptive trial designs, patient recruitment strategies, and data analysis techniques.

This session will focus on integrative strategies that combine various disciplines to advance cancer research. Topics will include collaborations between oncology, genomics, and bioinformatics to enhance understanding and treatment of cancer.

This track will highlight the latest trends in the discovery and development of anti-cancer drugs. Presentations will cover novel compounds, preclinical models, and the translation of findings from bench to bedside.